NVS Competitors & Alternatives
Compare Novartis AG ADR with similar stocks in the same industry
Drug Manufacturers - General
NVS
Main Stock$156.27
Tradestie Score
36
Market Cap
$254.99B
P/E Ratio
23.3
Revenue Growth
0.0%
Analyst Upside
-1.0%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$267.61
|
$448.07B | 39.1 | 59 | Compare |
|
ABBV
ABBVIE INC.
|
$285.19
|
$431.71B | 80.5 | 44 | Compare |
|
NVO
Novo-Nordisk A/S
|
$39.43
|
$262.92B | 9.6 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$172.57
|
$261.56B | 25.2 | 46 | Compare |
|
MRK
Merck & Co., Inc.
|
$147.24
|
$225.13B | 119.0 | 43 | Compare |
|
AMGN
Amgen Inc
|
$447.28
|
$160.70B | 27.2 | 35 | Compare |
|
PFE
Pfizer Inc.
|
$30.42
|
$154.70B | 39.3 | 35 | Compare |
|
GILD
Gilead Sciences Inc
|
$157.19
|
$137.92B | - | 43 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$41.96
|
$121.27B | 21.6 | 59 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$63.00
|
$96.54B | 13.5 | 44 | Compare |
More NVS Analysis
Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
17 stocks in this industry